Intratympanic corticosteroids in Ménière's disease: A mini-review [PDF]
Journal of Otology, 2017 This article reviews the effectiveness of intratympanic corticosteroids for vertigo control in Ménière's disease at 2-years follow-up according to the guidelines expressed by the American Academy of Otolaryngology-Head & Neck Surgery.
Mitesh Patel
doaj +9 more sources
Intratympanic steroid administration and predictors of recovery in sudden sensorineural hearing loss. [PDF]
PLoS ONEObjectivesSudden sensorineural hearing loss patient outcomes remain highly variable despite established treatment modalities. This study investigates the effects of treatment modalities, individual-level risk factors, and clinical presentation on sudden ...
Devin J Kennedy +8 more
doaj +2 more sources
Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies [PDF]
Toxics, 2015 Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ malignancies. However, serious side effects have been associated with its use, such as bilateral, progressive, irreversible, dose-dependent neurosensory ...
Angela Callejo +3 more
doaj +2 more sources
A Case of Binocular Vertical Diplopia after Intratympanic Gentamicin Therapy
European Journal of Case Reports in Internal Medicine, 2019 Intratympanic gentamicin therapy is a useful alternative treatment for refractory Meniere's disease and is generally well tolerated. Visual disturbances as side effects of this treatment are rarely reported in the literature.
Giacomo Cioffi +4 more
doaj +3 more sources
Journal of Otology, 2021 Objectives: To evaluate hearing outcome of salvage treatment with intratympanic steroids (ITS) in idiopathic sudden sensorineural hearing loss (ISSNHL) refractory to initial systemic steroid (SS) therapy.
Pedro Salvador +2 more
doaj +2 more sources
Potential Benefits of Flunarizine in Patients with Sudden Sensorineural Hearing Loss with Incomplete Recovery Following Conventional Steroid Treatment: A Retrospective Analysis [PDF]
MedicinaObjectives: This study assessed the potential benefits of supplemental flunarizine administration in patients with sudden sensorineural hearing loss (SSNHL) experiencing incomplete recovery with conventional steroid treatment.
Young-Soo Chang, Jeong Hwan Choi
doaj +2 more sources
The Egyptian Journal of Otolaryngology, 2019 Background In this report, we summarize our clinical experience with intratympanic (IT) dexamethasone treatment for control of idiopathic unilateral tinnitus when used as an adjunct treatment with Tricyclic antidepressant (TCA) imipramine hydrochloride ...
Tamer A. Abo El Ezz +2 more
doaj +2 more sources
Role of Transtympanic Steroid in Sudden Sensorineural Hearing Loss: A Retrospective Study [PDF]
Journal of Clinical and Diagnostic Research, 2021 Introduction: Sudden Sensorineural Hearing Loss (SNHL) is medical emergency in otology. The diagnosis and treatment of sudden SNHL remains a matter of discussion as no single treatment is gold standard. Antivirals, systemic and intratympanic steroids,
Vinish Kumar Agarwal +4 more
doaj +1 more source
Intratympanic Steroid for the Management of Sudden Hearing Loss: Introduction of a Tapering Method [PDF]
Iranian Journal of Otorhinolaryngology, 2022 Introduction:Sudden sensorineural hearing loss (SSNHL) is a therapeutic challenge. There are several controversies regarding the management protocol of SSNHL.
Mohsen Rajati +5 more
doaj +1 more source
Combination of Pulse Steroid with Intratympanic Injections in Sudden Sensorineural Hearing Loss [PDF]
Iranian Journal of Otorhinolaryngology, 2021 Introduction: Oral prednisolone was suggested as the first step to treat idiopathic sudden sensorineural hearing loss (ISSHL). This study aimed to investigate the effect of pulse therapy with methylprednisolone and intratympanic methylprednisolone ...
Maryam Amizadeh +3 more
doaj +1 more source